Cargando…

Association of Acid Suppression and Antimicrobial Use with Clostridium difficile Infection in Children

BACKGROUND: Clostridium difficileinfections (CDIs) can cause severe diarrhea and be potentially life-threatening, especially in children. Possible risk factors include age, being immunocompromised, prior antibiotic exposure, the use of antacids, and diseases that alter intestinal microbiota. Data in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huynh, Hoang A, Wisdom, Christy, Maples, Holly D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631180/ http://dx.doi.org/10.1093/ofid/ofx163.999

Ejemplares similares

Risk Factors for Community-Associated Clostridium difficile Infection in Children
por: Weng, Mark, et al.
Publicado: (2017)

The Impact of Diagnostic Stewardship on Clostridium difficile Infections
por: Bischoff, Werner, et al.
Publicado: (2017)

1644 Risk Factors for Community-Associated Clostridium difficile Infection in Children
por: Crews, Jonathan, et al.
Publicado: (2014)

Clostridium difficile Molecular Epidemiology in a Prospective Cohort of Canadian Children Compared with Cases of C. difficile Infection
por: Lloyd, Colin, et al.
Publicado: (2017)

2425. Correlating Use of High-Risk Antimicrobials and the Incidence of Hospital-Onset Clostridium difficile Infection: Targeting Prescribing Trends for Antimicrobial Stewardship
por: Thottacherry, Elizabeth, et al.
Publicado: (2019)

2396. Clostridium difficile Infection is Children with Sickle Cell Disease: An Uncommon Entity
por: Lee, Philip, et al.
Publicado: (2019)

Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017)

Reduction of Clostridium difficile Infection in a Community Teaching Hospital Associated with Antimicrobial Stewardship Team Interventions on Fluoroquinolone Utilization
por: Politis, Paula, et al.
Publicado: (2017)

507. Degree of Concordance of Clostridium difficile Strains in Adults with Community-Associated C. difficile Infection and Infants With C. difficile Colonization
por: Clayton, Jason A, et al.
Publicado: (2018)

Risk Factors for Recurrent Pedatric Community Associated Clostridium difficile Infection
por: Parmar, Deepika, et al.
Publicado: (2017)

2372. PCR Ribotype and Antimicrobial Susceptibility of Clostridioides (Formerly Clostridium) difficile in Korea
por: Hoo Jeon, Cheon, et al.
Publicado: (2019)

Effect of Leadership Commitment and Education on Antimicrobial Use and Hospital-Acquired Clostridium difficile infection rates at a Community Hospital
por: Smoke, Steven, et al.
Publicado: (2017)

Use of Electronic Data to Identify Risk Factors Associated with Clostridium difficile Infection (CDI) and to Develop CDI Risk Scores
por: Aukes, Laurie, et al.
Publicado: (2017)

Novel Antimicrobials for the Treatment of Clostridium difficile Infection
por: Petrosillo, Nicola, et al.
Publicado: (2018)

1646 Evidence of hospital-associated Clostridium difficile transmission between patients with asymptomatic carriage and patients with Clostridium difficile infection
por: Galdys, Alison, et al.
Publicado: (2014)

1641. Treatment of Recurrent Clostridium difficile Infection With SER-109 Reduces Gastrointestinal Carriage of Antimicrobial Resistance Genes
por: Ford, Christopher, et al.
Publicado: (2018)

1990. A Strategy of Mandatory Infectious Disease Consultations on Hospital-acquired Clostridium difficile Infection and Antimicrobial Utilization
por: Hou, Cindy, et al.
Publicado: (2019)

Impact of System-wide Adoption of CDC Core Elements on Antimicrobial Use and Clostridium difficile Infection in a Large Health System
por: Guharoy, Roy, et al.
Publicado: (2017)

Incidence of Pediatric Community Associated Clostridium Difficile Infection Following Common Antibotics
por: Katz, Margot Miranda, et al.
Publicado: (2017)

2355. The Association Between Diagnostic Testing Method and Clostridium difficile Infection Severity
por: Menon, Anitha, et al.
Publicado: (2019)

239. Implementation of a Vertical Antimicrobial Stewardship Intervention for Patients Colonized with Clostridium difficile
por: Revolinski, Sara, et al.
Publicado: (2018)

497. Identification of Patients at Risk of Clostridium difficile Infection for Enrollment in Vaccine Clinical Trials
por: Stevens, Vanessa, et al.
Publicado: (2018)

Evaluating the Effectiveness of an Antimicrobial Stewardship Intervention on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection
por: Didiodato, Giulio, et al.
Publicado: (2015)

Socioeconomic Status Factors Associated with Increased Incidence of Community-Associated Clostridium difficile Infection
por: Skrobarcek, Kimberly, et al.
Publicado: (2017)

494. Use of a Clinical Prediction Tool to Predict Clostridium difficile Infection
por: Hawkins, Marten, et al.
Publicado: (2018)

1889. A Clinical Practice Assessment on Clostridium difficile Infection
por: Lubarda, Jovana, et al.
Publicado: (2018)

468. Diagnosis of Clinical Clostridium difficile Infection: An Unmet Challenge
por: Vyas, Neeti, et al.
Publicado: (2018)

Ridinilazole: a novel antimicrobial for Clostridium difficile infection
por: Cho, Jonathan C., et al.
Publicado: (2019)

518. Modeling the Potential Impact of Administering Vaccines Against Clostridium difficile Infection to Individuals in Healthcare Facilities
por: Toth, Damon, et al.
Publicado: (2018)

502. Enhanced Sporulation and Vancomycin Resistance Associated With Clostridium difficile From Recurrent Infections
por: Tijerina-Rodriguez, Laura E, et al.
Publicado: (2018)

Endogenous Serum IgG Antibodies to Clostridium difficile Toxin B Are Associated with Protection against C. difficile Infection Recurrence
por: Kelly, Ciaran P, et al.
Publicado: (2017)

1710. Clostridioides difficile Bundle Implementation Reduces Unnecessary Testing in Pediatric Patients
por: Sietsema, Lydia, et al.
Publicado: (2023)

External validation of predictive scores for mortality following Clostridium difficile infection
por: Beauregard-Paultre, Catherine, et al.
Publicado: (2017)

External validation of clinical scores to predict complications of Clostridium difficile infection
por: Beauregard-Paultre, Catherine, et al.
Publicado: (2017)

Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017)

490. Comparison of Clostridium difficile Infection Outcomes by Diagnostic Testing Method
por: Guh, Alice, et al.
Publicado: (2018)

483. Clinical Characteristics of Military Trauma Patients With Clostridium difficile Infections
por: Schall, Sarah, et al.
Publicado: (2018)

2673. Risk Factors for Clostridium difficile Infection in Lung Transplant Patients
por: DeRose, Joseph L, et al.
Publicado: (2019)

2365. Volatile Metabolite-Based Detection of Clostridium difficile Infection (CDI)
por: Aloum, Obadah, et al.
Publicado: (2019)

619. Intestinal Microbiome Changes Associated with Immune Status and Clostridium difficile Colonization in Hospitalized Children
por: Mohandas, Sindhu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_20i6iauontuolt7to8p81no3fh